The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Compound Formula Granules Market Research Report 2024
Synopsis
Global Compound Formula Granules market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Compound Formula Granules market research.
Key companies engaged in the Compound Formula Granules industry include China TCM, Tianjin Chase Sun Pharmaceutical Co.,Ltd, China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd., China Shineway Pharm., Purapharm Corporation Limited, Xinlvse Pharmaceutical Industry Technology Development Co., Ltd, Guangxi LiuYao Group Co., Ltd, Jilin Aodong Pharmaceutical Group Co.,Ltd. and Jiangsu Kanion Pharmaceutical Co.,Ltd, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Compound Formula Granules were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Compound Formula Granules market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Compound Formula Granules market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
China TCM
Tianjin Chase Sun Pharmaceutical Co.,Ltd
China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.
China Shineway Pharm.
Purapharm Corporation Limited
Xinlvse Pharmaceutical Industry Technology Development Co., Ltd
Guangxi LiuYao Group Co., Ltd
Jilin Aodong Pharmaceutical Group Co.,Ltd.
Jiangsu Kanion Pharmaceutical Co.,Ltd
Chongqing Taiji Industry (Group) Co.,Ltd.
Shanghai Pharmaceuticals Holding Co.,Ltd.
Shijiazhuang Yiling Pharmaceutical Co.,Ltd
Tasly Holding Group
HeiLongJiang ZBD Pharmaceutical Co., Ltd
Zhejiang Jolly Pharmaceutical Co., Ltd.
Segment by Type
Premixed Packaging
Individually Packaging
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Compound Formula Granules report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Global Compound Formula Granules market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Compound Formula Granules market research.
Key companies engaged in the Compound Formula Granules industry include China TCM, Tianjin Chase Sun Pharmaceutical Co.,Ltd, China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd., China Shineway Pharm., Purapharm Corporation Limited, Xinlvse Pharmaceutical Industry Technology Development Co., Ltd, Guangxi LiuYao Group Co., Ltd, Jilin Aodong Pharmaceutical Group Co.,Ltd. and Jiangsu Kanion Pharmaceutical Co.,Ltd, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Compound Formula Granules were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Compound Formula Granules market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Compound Formula Granules market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
China TCM
Tianjin Chase Sun Pharmaceutical Co.,Ltd
China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.
China Shineway Pharm.
Purapharm Corporation Limited
Xinlvse Pharmaceutical Industry Technology Development Co., Ltd
Guangxi LiuYao Group Co., Ltd
Jilin Aodong Pharmaceutical Group Co.,Ltd.
Jiangsu Kanion Pharmaceutical Co.,Ltd
Chongqing Taiji Industry (Group) Co.,Ltd.
Shanghai Pharmaceuticals Holding Co.,Ltd.
Shijiazhuang Yiling Pharmaceutical Co.,Ltd
Tasly Holding Group
HeiLongJiang ZBD Pharmaceutical Co., Ltd
Zhejiang Jolly Pharmaceutical Co., Ltd.
Segment by Type
Premixed Packaging
Individually Packaging
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Compound Formula Granules report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Compound Formula Granules Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Premixed Packaging
1.2.3 Individually Packaging
1.3 Market by Application
1.3.1 Global Compound Formula Granules Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Compound Formula Granules Market Perspective (2018-2029)
2.2 Compound Formula Granules Growth Trends by Region
2.2.1 Global Compound Formula Granules Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Compound Formula Granules Historic Market Size by Region (2018-2023)
2.2.3 Compound Formula Granules Forecasted Market Size by Region (2024-2029)
2.3 Compound Formula Granules Market Dynamics
2.3.1 Compound Formula Granules Industry Trends
2.3.2 Compound Formula Granules Market Drivers
2.3.3 Compound Formula Granules Market Challenges
2.3.4 Compound Formula Granules Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Compound Formula Granules Players by Revenue
3.1.1 Global Top Compound Formula Granules Players by Revenue (2018-2023)
3.1.2 Global Compound Formula Granules Revenue Market Share by Players (2018-2023)
3.2 Global Compound Formula Granules Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Compound Formula Granules Revenue
3.4 Global Compound Formula Granules Market Concentration Ratio
3.4.1 Global Compound Formula Granules Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Compound Formula Granules Revenue in 2022
3.5 Compound Formula Granules Key Players Head office and Area Served
3.6 Key Players Compound Formula Granules Product Solution and Service
3.7 Date of Enter into Compound Formula Granules Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Compound Formula Granules Breakdown Data by Type
4.1 Global Compound Formula Granules Historic Market Size by Type (2018-2023)
4.2 Global Compound Formula Granules Forecasted Market Size by Type (2024-2029)
5 Compound Formula Granules Breakdown Data by Application
5.1 Global Compound Formula Granules Historic Market Size by Application (2018-2023)
5.2 Global Compound Formula Granules Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Compound Formula Granules Market Size (2018-2029)
6.2 North America Compound Formula Granules Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Compound Formula Granules Market Size by Country (2018-2023)
6.4 North America Compound Formula Granules Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Compound Formula Granules Market Size (2018-2029)
7.2 Europe Compound Formula Granules Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Compound Formula Granules Market Size by Country (2018-2023)
7.4 Europe Compound Formula Granules Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Compound Formula Granules Market Size (2018-2029)
8.2 Asia-Pacific Compound Formula Granules Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Compound Formula Granules Market Size by Region (2018-2023)
8.4 Asia-Pacific Compound Formula Granules Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Compound Formula Granules Market Size (2018-2029)
9.2 Latin America Compound Formula Granules Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Compound Formula Granules Market Size by Country (2018-2023)
9.4 Latin America Compound Formula Granules Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Compound Formula Granules Market Size (2018-2029)
10.2 Middle East & Africa Compound Formula Granules Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Compound Formula Granules Market Size by Country (2018-2023)
10.4 Middle East & Africa Compound Formula Granules Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 China TCM
11.1.1 China TCM Company Detail
11.1.2 China TCM Business Overview
11.1.3 China TCM Compound Formula Granules Introduction
11.1.4 China TCM Revenue in Compound Formula Granules Business (2018-2023)
11.1.5 China TCM Recent Development
11.2 Tianjin Chase Sun Pharmaceutical Co.,Ltd
11.2.1 Tianjin Chase Sun Pharmaceutical Co.,Ltd Company Detail
11.2.2 Tianjin Chase Sun Pharmaceutical Co.,Ltd Business Overview
11.2.3 Tianjin Chase Sun Pharmaceutical Co.,Ltd Compound Formula Granules Introduction
11.2.4 Tianjin Chase Sun Pharmaceutical Co.,Ltd Revenue in Compound Formula Granules Business (2018-2023)
11.2.5 Tianjin Chase Sun Pharmaceutical Co.,Ltd Recent Development
11.3 China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.
11.3.1 China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd. Company Detail
11.3.2 China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd. Business Overview
11.3.3 China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd. Compound Formula Granules Introduction
11.3.4 China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd. Revenue in Compound Formula Granules Business (2018-2023)
11.3.5 China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd. Recent Development
11.4 China Shineway Pharm.
11.4.1 China Shineway Pharm. Company Detail
11.4.2 China Shineway Pharm. Business Overview
11.4.3 China Shineway Pharm. Compound Formula Granules Introduction
11.4.4 China Shineway Pharm. Revenue in Compound Formula Granules Business (2018-2023)
11.4.5 China Shineway Pharm. Recent Development
11.5 Purapharm Corporation Limited
11.5.1 Purapharm Corporation Limited Company Detail
11.5.2 Purapharm Corporation Limited Business Overview
11.5.3 Purapharm Corporation Limited Compound Formula Granules Introduction
11.5.4 Purapharm Corporation Limited Revenue in Compound Formula Granules Business (2018-2023)
11.5.5 Purapharm Corporation Limited Recent Development
11.6 Xinlvse Pharmaceutical Industry Technology Development Co., Ltd
11.6.1 Xinlvse Pharmaceutical Industry Technology Development Co., Ltd Company Detail
11.6.2 Xinlvse Pharmaceutical Industry Technology Development Co., Ltd Business Overview
11.6.3 Xinlvse Pharmaceutical Industry Technology Development Co., Ltd Compound Formula Granules Introduction
11.6.4 Xinlvse Pharmaceutical Industry Technology Development Co., Ltd Revenue in Compound Formula Granules Business (2018-2023)
11.6.5 Xinlvse Pharmaceutical Industry Technology Development Co., Ltd Recent Development
11.7 Guangxi LiuYao Group Co., Ltd
11.7.1 Guangxi LiuYao Group Co., Ltd Company Detail
11.7.2 Guangxi LiuYao Group Co., Ltd Business Overview
11.7.3 Guangxi LiuYao Group Co., Ltd Compound Formula Granules Introduction
11.7.4 Guangxi LiuYao Group Co., Ltd Revenue in Compound Formula Granules Business (2018-2023)
11.7.5 Guangxi LiuYao Group Co., Ltd Recent Development
11.8 Jilin Aodong Pharmaceutical Group Co.,Ltd.
11.8.1 Jilin Aodong Pharmaceutical Group Co.,Ltd. Company Detail
11.8.2 Jilin Aodong Pharmaceutical Group Co.,Ltd. Business Overview
11.8.3 Jilin Aodong Pharmaceutical Group Co.,Ltd. Compound Formula Granules Introduction
11.8.4 Jilin Aodong Pharmaceutical Group Co.,Ltd. Revenue in Compound Formula Granules Business (2018-2023)
11.8.5 Jilin Aodong Pharmaceutical Group Co.,Ltd. Recent Development
11.9 Jiangsu Kanion Pharmaceutical Co.,Ltd
11.9.1 Jiangsu Kanion Pharmaceutical Co.,Ltd Company Detail
11.9.2 Jiangsu Kanion Pharmaceutical Co.,Ltd Business Overview
11.9.3 Jiangsu Kanion Pharmaceutical Co.,Ltd Compound Formula Granules Introduction
11.9.4 Jiangsu Kanion Pharmaceutical Co.,Ltd Revenue in Compound Formula Granules Business (2018-2023)
11.9.5 Jiangsu Kanion Pharmaceutical Co.,Ltd Recent Development
11.10 Chongqing Taiji Industry (Group) Co.,Ltd.
11.10.1 Chongqing Taiji Industry (Group) Co.,Ltd. Company Detail
11.10.2 Chongqing Taiji Industry (Group) Co.,Ltd. Business Overview
11.10.3 Chongqing Taiji Industry (Group) Co.,Ltd. Compound Formula Granules Introduction
11.10.4 Chongqing Taiji Industry (Group) Co.,Ltd. Revenue in Compound Formula Granules Business (2018-2023)
11.10.5 Chongqing Taiji Industry (Group) Co.,Ltd. Recent Development
11.11 Shanghai Pharmaceuticals Holding Co.,Ltd.
11.11.1 Shanghai Pharmaceuticals Holding Co.,Ltd. Company Detail
11.11.2 Shanghai Pharmaceuticals Holding Co.,Ltd. Business Overview
11.11.3 Shanghai Pharmaceuticals Holding Co.,Ltd. Compound Formula Granules Introduction
11.11.4 Shanghai Pharmaceuticals Holding Co.,Ltd. Revenue in Compound Formula Granules Business (2018-2023)
11.11.5 Shanghai Pharmaceuticals Holding Co.,Ltd. Recent Development
11.12 Shijiazhuang Yiling Pharmaceutical Co.,Ltd
11.12.1 Shijiazhuang Yiling Pharmaceutical Co.,Ltd Company Detail
11.12.2 Shijiazhuang Yiling Pharmaceutical Co.,Ltd Business Overview
11.12.3 Shijiazhuang Yiling Pharmaceutical Co.,Ltd Compound Formula Granules Introduction
11.12.4 Shijiazhuang Yiling Pharmaceutical Co.,Ltd Revenue in Compound Formula Granules Business (2018-2023)
11.12.5 Shijiazhuang Yiling Pharmaceutical Co.,Ltd Recent Development
11.13 Tasly Holding Group
11.13.1 Tasly Holding Group Company Detail
11.13.2 Tasly Holding Group Business Overview
11.13.3 Tasly Holding Group Compound Formula Granules Introduction
11.13.4 Tasly Holding Group Revenue in Compound Formula Granules Business (2018-2023)
11.13.5 Tasly Holding Group Recent Development
11.14 HeiLongJiang ZBD Pharmaceutical Co., Ltd
11.14.1 HeiLongJiang ZBD Pharmaceutical Co., Ltd Company Detail
11.14.2 HeiLongJiang ZBD Pharmaceutical Co., Ltd Business Overview
11.14.3 HeiLongJiang ZBD Pharmaceutical Co., Ltd Compound Formula Granules Introduction
11.14.4 HeiLongJiang ZBD Pharmaceutical Co., Ltd Revenue in Compound Formula Granules Business (2018-2023)
11.14.5 HeiLongJiang ZBD Pharmaceutical Co., Ltd Recent Development
11.15 Zhejiang Jolly Pharmaceutical Co., Ltd.
11.15.1 Zhejiang Jolly Pharmaceutical Co., Ltd. Company Detail
11.15.2 Zhejiang Jolly Pharmaceutical Co., Ltd. Business Overview
11.15.3 Zhejiang Jolly Pharmaceutical Co., Ltd. Compound Formula Granules Introduction
11.15.4 Zhejiang Jolly Pharmaceutical Co., Ltd. Revenue in Compound Formula Granules Business (2018-2023)
11.15.5 Zhejiang Jolly Pharmaceutical Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
